Classification of surgical causes of and approaches to the chronically failing ileoanal pouch.

Journal Information

Full Title: Tech Coloproctol

Abbreviation: Tech Coloproctol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestNone related to the current paper. EMP, MR, CB had none to declare. RH: Educational Grant: Stryker. Consulting fees: Applied Medical. Speaker fees: Applied Medical, Medtronic, Johnson & Johnson. Stock options: SurgEase. MD: Advisory fees: Echo Pharma, Alimentiv (formerly Robarts Clinical Trials). Unrestricted Grant: Pfizer. Speaker fees: Janssen, Merck & Co., Inc., Pfizer, Takeda, Tillotts Pharma, Galapagos, BMS. Nonfinancial support: Dr. Falk Pharma. WB: Speaker fees: Takeda, Johnson & Johnson, Medtronic, Braun. Grant: VIFOR, Braun. Ethics approval statementAccording to local law and the Medical Ethical Committee at the Amsterdam UMC, ethical approval was waived for this retrospective study. Patient informed consent statementAll eligible patients received an opt-out letter and could withdraw permission to collect data for this study. Conflict of interest None related to the current paper. EMP, MR, CB had none to declare. RH: Educational Grant: Stryker. Consulting fees: Applied Medical. Speaker fees: Applied Medical, Medtronic, Johnson & Johnson. Stock options: SurgEase. MD: Advisory fees: Echo Pharma, Alimentiv (formerly Robarts Clinical Trials). Unrestricted Grant: Pfizer. Speaker fees: Janssen, Merck & Co., Inc., Pfizer, Takeda, Tillotts Pharma, Galapagos, BMS. Nonfinancial support: Dr. Falk Pharma. WB: Speaker fees: Takeda, Johnson & Johnson, Medtronic, Braun. Grant: VIFOR, Braun."

Evidence found in paper:

"Funding None."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025